Screener
Theravance Biopharma TBPH Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Theravance Biopharma in its filing.
Tagged under the XBRL concept us-gaap:ProfitLoss.
The source filing: Theravance Biopharma’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 8:00 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-093773
FAQ
- What is Theravance Biopharma's net income?
- Theravance Biopharma (TBPH) reported net income of -$5.9M in Q2 2026.
- How has Theravance Biopharma's net income changed year-over-year?
- Theravance Biopharma's net income decreased by 110.8% year-over-year, from $54.84M to -$5.9M.
- What is the long-term trend for Theravance Biopharma's net income?
- Over 4 years (2021 to 2025), Theravance Biopharma's net income has grown at a -14.6% compound annual growth rate (CAGR), from -$199.43M to $105.9M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.
Ask your AI about Theravance Biopharma's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude